The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)

CANCER RESEARCH

AMER ASSOC CANCER RESEARCH

1. Cancer Research UK [7741] Funding Source: researchfish